Nasrullah Adeel, Javed Anam, Tariq Usman, Young Meilin, Moeen Zunera, Balaan Marvin
Department of Internal Medicine, Allegheny Health Network; Pittsburgh, USA.
Department of Internal Medicine, University College of Medicine and Dentistry, Lahore, Pakistan.
Eur J Case Rep Intern Med. 2019 Dec 30;7(1):001373. doi: 10.12890/2019_001373. eCollection 2020.
Infectious purpura fulminans (PF) is a rare presentation of disseminated intravascular coagulopathy (DIC) due to diffuse intravascular thrombosis and haemorrhagic infarction of the skin. PF can present in infancy/childhood or adulthood and usually presents as ecchymotic skin lesions, fever and hypotension. It is most commonly a consequence of sepsis related to , or . Despite aggressive management of sepsis with intravenous fluids, antibiotics, and conventional and nonconventional therapies, the condition still carries a mortality rate of 43%. mostly presents with community-acquired pneumonia. We present a case of PF secondary to DIC related to Pneumococcal sepsis in an otherwise healthy and immunocompetent patient.
Infectious purpura fulminans is a haematological emergency that demands early recognition and timely institution of therapy to prevent significant morbidity and mortality.A characteristic skin rash is a key diagnostic clue pointing to purpura fulminans, and should lead to prompt institution of therapy, as waiting for a skin biopsy result can delay the diagnosis and result in significant morbidity and mortality.Due to the lack of prospective data on management of the condition, various modalities, such as hyperbaric oxygen therapy and IVIG, still have questionable benefits. We therefore aim to expand knowledge of purpura fulminans management.
感染性暴发性紫癜(PF)是由于弥漫性血管内血栓形成和皮肤出血性梗死导致的播散性血管内凝血(DIC)的一种罕见表现。PF可发生于婴儿期/儿童期或成人期,通常表现为瘀斑性皮肤病变、发热和低血压。它最常见于与 、 或 相关的败血症。尽管通过静脉输液、抗生素以及传统和非传统疗法对败血症进行积极治疗,但该疾病的死亡率仍为43%。 大多表现为社区获得性肺炎。我们报告一例在其他方面健康且免疫功能正常的患者中,继发于与肺炎球菌败血症相关的DIC的PF病例。
感染性暴发性紫癜是一种血液学急症,需要早期识别并及时进行治疗,以预防严重的发病和死亡。特征性皮疹是指向暴发性紫癜的关键诊断线索,应促使迅速开始治疗,因为等待皮肤活检结果会延迟诊断并导致严重的发病和死亡。由于缺乏关于该疾病治疗的前瞻性数据,各种治疗方式,如高压氧治疗和静脉注射免疫球蛋白,其益处仍存在疑问。因此,我们旨在扩大对暴发性紫癜治疗的认识。